Ayumantra Amaltas (PUR) Capsules
Natural health product licensed in Canada
If this product were sold in France
- Conditions légales
Cassia fistula L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans, aux femmes enceintes et allaitantes et une mention déconseillant l'usage prolongé.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Cassia fistula Source : Chair (fruit) Extract : Matériel brut sec Extraction ratio : 2.174:1 Dry plant equivalent : 1.25 g | 575 mg | Not calculated |
Non-medicinal ingredients
Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | minimum: 1 Capsule ; maximum: 4 Capsule | 1 Tous les jours |
Uses authorised in Canada
Traditionally used in Ayurveda as a stimulant laxative to help relieve Vibandha (constipation).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Product record
- Licence holder
- AYUMANTRA INC.
- NPN or DIN-HM
- 80090445
- Status
- Active licence
- Licence date
- 5 February 2019
- Revision date
- 12 May 2026
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Traditionnelle
Source
Official Health Canada record, licence 80090445
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Ayumantra Amaltas (PUR) Capsules”, https://compoatlas.com/en/supplements/canada/80090445-ayumantra-amaltas-pur-capsules, updated 12 May 2026.